Catalyst Wire Dossier Catalyst Wire Dossier

Zafiride

· MolMed SpA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zafiride, covering 2018-02-08 to 2018-02-08. Get the full timeline:

Most recent: EMA Application withdrawn: Zafiride — MolMed SpA

See pricing